• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • Fast Track Update
  • News

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

NMPA Encourages High-quality Development Of Medical Device Industry

2022-02-23

In 2021, NMPA continues to encourage high-quality development of medical device industry through innovation pathway, priority pathway, real…

NMPA New Regulatory Framework Summary In 2021

2022-02-16

In 2021, China NMPA established new regulatory framework for medical device registration. The below is a list of…

China NMPA Newsletter – December 2021

2022-01-25

Inspirative Medical – A BradyKnows Company December 2021 China NMPA Newsletter Official Publication of BradyKnows 【Deadline】 2021 Annual…

NMPA On Issuing Relevant Technical Guidelines In December 2021

2022-01-20

In order to strengthen the supervision and guidance of medical device product registration and further improve the quality…

【Deadline】 2021 Annual Quality System Self-Inspection Report To China NMPA

2022-01-18

Dear Medical Device Manufacturers, Here is a kind REMINDER to manufacturers operating Class III medical devices in China,…

NMPA Collect Public Opinions On Termination Of Old GCP

2022-01-14

On Jan 12, 2022, NMPA issued a notice on its website to collect public opinions on termination of…

New Batch Of China Medical Device Catalogue Modification

2022-01-05

On Dec 27, 2021, Center for Medical Device Standardization Administration of NMPA published a notice to collect public…

NMPA Notice On Deadline Of Paying Review Fee For Registration

2022-01-05

On Dec 1, 2021, NMPA published a notice on the deadline of paying review fee for registration.  After…

China Continues To Enhance Post Market Surveillance On Medical Devices

2021-12-17

Since the implementation of Order 739 Regulations on Supervision and Administration of Medical Devices in June, 2021, China…

China NMPA Newsletter – November 2021

2021-12-15

Inspirative Medical – A BradyKnows Company November 2021 China NMPA Newsletter Official Publication of BradyKnows New E-filing Catalogue…

More Source Data Required For NMPA Clinical Trial Data Submission

2021-12-14

On Nov 25, 2021, NMPA published two guidelines on clinical data submission requirement for medical device and IVD…

How To Handle China Registration During The Transition Period From Old NMPA Requirements To New Requirements

2021-12-08

The Administrative Measures for Registration and Filing of Medical Devices (Order No. 47) and the Administrative Measures for…
« Prev...246...1112131415...18...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7